Radparvar S, Mellon W S
J Steroid Biochem. 1984 Apr;20(4A):807-15. doi: 10.1016/0022-4731(84)90388-1.
Steroid hormone receptors, including those for vitamin D3, contain reactive sulfhydryl group(s) essential for hormone binding. On this basis, several compounds that are capable of interacting with sulfhydryl groups were tested for their ability to dissociate 1,25-dihydroxyvitamin D3 from chicken intestinal receptors. At concentrations resulting in 50% displacement of specifically bound cytoplasmic 1,25-dihydroxyvitamin D3, the order of potency for these displacing reagents is mersalyl acid greater than sodium thiocyanate approximately equal to p-hydroxymercuribenzoate approximately equal to mercuric chloride much greater than 5,5'-dithiobis-(2-nitrobenzoic acid). Hormone displacement by mersalyl acid and p-hydroxymercuribenzoate was completely reversible upon dithiothreitol addition. In contrast limited rebinding of 1,25-dihydroxyvitamin D3 occurred after, 5,5-dithiobis-(2-nitrobenzoic acid) and mercuric chloride treatment. Furthermore, at least for mersalyl acid treatment, hormone displacement and subsequent regeneration of sterol binding did not seem to alter the integrity of the receptor as evidenced by sucrose gradient analysis, DNA-cellulose and phosphocellulose chromatography. Additionally, treatment of the nuclear 1,25-dihydroxyvitamin D3 receptor did not significantly affect the apparent equilibrium dissociation constant for hormone binding (Kd = 2.7 X 10(-10) M; Kd = 1.7 X 10(-10) M, for control and mersalyl acid treated receptor, respectively). Finally, a method has been developed for measurement of occupied 1,25-dihydroxyvitamin D3 receptors. The unfilled receptors were quantitated in the cytoplasm or chromatin extracted fraction by incubation with radioactive 1,25-dihydroxyvitamin D3 at 0-4 degrees C for 3-6 h without interference from previously filled sites. The total receptor measurement is carried out by incubation of cytosol or nuclear extract with 0.5-1.0 mM mersalyl acid for 1.0 h. Exchange of radioactive sterol for the bound nonradioactive sterol is accomplished by incubation with 1-2 mM dithiothreitol and 1.0 nM radioactive 1,25-dihydroxyvitamin D3 at 0-4 degrees C for 16 h. Subtracting the unfilled sites from total sites results in a measurement of filled sites. With this exchange assay, estimates of total receptor in untreated and 1,25-dihydroxyvitamin D3 treated chicks (estimated 2 h after injection of doses 0.3-300 nmol) were not significantly different (66.2 +/- 4.5 versus 64.4 +/- 10.4 to 69.0 +/- 5.9 pg/mg protein, respectively). Furthermore, quantitation of total receptor by direct or exchange assay obtained from in vitro incubations of intestinal slices with radioactive and nonradioactive 1,25-dihydroxyvitamin D3 were not
类固醇激素受体,包括维生素D3的受体,含有对激素结合至关重要的反应性巯基。基于此,测试了几种能够与巯基相互作用的化合物将1,25 - 二羟基维生素D3从鸡肠道受体上解离的能力。在导致特异性结合的细胞质1,25 - 二羟基维生素D3发生50%置换的浓度下,这些置换试剂的效力顺序为:汞撒利酸大于硫氰酸钠,硫氰酸钠约等于对羟基汞苯甲酸,对羟基汞苯甲酸约等于氯化汞,氯化汞远大于5,5'-二硫代双-(2 - 硝基苯甲酸)。加入二硫苏糖醇后,汞撒利酸和对羟基汞苯甲酸引起的激素置换是完全可逆的。相比之下,5,5 - 二硫代双-(2 - 硝基苯甲酸)和氯化汞处理后,1,25 - 二羟基维生素D3的再结合有限。此外,至少对于汞撒利酸处理而言,蔗糖梯度分析、DNA - 纤维素和磷酸纤维素色谱分析表明,激素置换以及随后甾醇结合的再生似乎并未改变受体的完整性。另外,对核1,25 - 二羟基维生素D3受体的处理并未显著影响激素结合的表观平衡解离常数(分别为对照组和汞撒利酸处理组的Kd = 2.7×10(-10) M;Kd = 1.7×10(-10) M)。最后,已开发出一种测量被占据的1,25 - 二羟基维生素D3受体的方法。通过在0 - 4℃下与放射性1,25 - 二羟基维生素D3孵育3 - 6小时,对细胞质或染色质提取物中的未填充受体进行定量,而不受先前填充位点的干扰。通过将细胞质溶胶或核提取物与0.5 - 1.0 mM汞撒利酸孵育1.0小时来进行总受体测量。通过在0 - 4℃下与1 - 2 mM二硫苏糖醇和1.0 nM放射性1,25 - 二羟基维生素D3孵育16小时,使放射性甾醇与结合的非放射性甾醇进行交换。用总位点减去未填充位点可得到填充位点的测量值。通过这种交换测定法,未处理和1,25 - 二羟基维生素D3处理的雏鸡(注射剂量0.3 - 300 nmol后约2小时进行估计)中总受体的估计值无显著差异(分别为66.2±4.5与64.4±10.4至69.0±5.9 pg/mg蛋白质)。此外,通过直接或交换测定法对从用放射性和非放射性1,25 - 二羟基维生素D3进行体外孵育的肠切片中获得的总受体进行定量,结果并不……